封面
市場調查報告書
商品編碼
2126619

心臟移植市場:依移植類型、捐贈者類型、適應症、最終用戶和地區分類。

Heart Transplant Market, By Transplant Type, By Donor Type, By Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年心臟移植市場價值為141.2億美元,預計到2033年將達到286.5億美元。預計從2026年到2033年,該市場將以10.6%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 141.2億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 10.60% 2033年市場規模預測: 286.5億美元

全球心臟移植市場是心血管醫學領域的重要組成部分,涵蓋醫療設備、免疫抑制劑、器官保存方案以及末期心臟衰竭患者的循環系統後護理產品。心臟移植仍然是治療對常規療法無效的嚴重難治性心臟衰竭的主要方法。外科手術技術、器官保存和免疫抑制技術的進步顯著改善了患者的預後。

全球心臟移植市場的成長主要受以下因素驅動:缺血性心臟病和心肌病等心血管疾病負擔日益加重、移植基礎設施不斷完善以及器官捐贈和分配系統的發展。此外,臨床意識的提高、醫療保健支出的增加以及保存和監測技術的進步,也進一步推動了已開發市場和新興市場對心臟移植的接受度。

市場動態

全球心臟移植市場成長的主要驅動力是與心血管疾病、糖尿病、肥胖和高血壓相關的末期心臟衰竭負擔日益加重。機械循環支持裝置(如左心室輔助裝置 (LVAD))的出現、體外器官灌注技術以及保存技術的進步,都有助於改善患者管理並增加可移植心臟的供應。已開發市場和新興市場對移植基礎設施、器官捐贈和移植登記系統的投入增加,也促進了市場成長。

然而,心臟移植市場的成長受到許多因素的限制,例如捐贈心臟長期短缺、移植手術和終身術後護理的高昂費用,以及器官排斥和感染疾病等併發症。儘管如此,異種移植、生物工程心臟技術以及亞太地區、拉丁美洲和中東地區移植能力的提升,為克服器官短缺和擴大先進心臟衰竭治療的覆蓋範圍提供了重要機會。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球心臟移植市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球心臟移植市場報告的目標受群眾外包括業內各方相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球心臟移植市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章 全球心臟移植市場:依移植類型分類,2021-2033年

  • 原位心臟移植
  • 異位心臟移植

第5章 全球心臟移植市場:依捐贈者類型分類,2021-2033年

  • 腦死後器官捐贈(DBD)
  • 循環停止後器官捐贈(DCD)

第6章 全球心臟移植市場:依適應症分類,2021-2033年

  • 末期心臟衰竭
  • 心肌病
  • 先天性心臟病
  • 其他

第7章 全球心臟移植市場:依最終用戶分類,2021-2033年

  • 醫院
  • 心臟移植專科中心
  • 學術研究機構
  • 其他

第8章 全球心臟移植市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • 公司簡介
    • TransMedics Group, Inc.
    • XVIVO
    • Getinge AB
    • Terumo Corporation
    • Bridge to Life Ltd.
    • Organ Recovery Systems, Inc.
    • Paragonix Technologies, Inc.
    • Preservation Solutions, Inc.
    • Global Transplant Solutions, Inc.
    • LivaNova PLC

第10章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9945

Heart Transplant Market is estimated to be valued at USD 14.12 Bn in 2026 and is expected to reach USD 28.65 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 14.12 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.60% 2033 Value Projection: USD 28.65 Bn

The global heart transplant market is an important part of cardiovascular medicine that includes medical devices, immunosuppressive drugs, organ preservation solutions and post-transplant care products for patients with end-stage heart failure. Heart transplantation continues to be a mainstay of treatment for severe refractory heart failure that is unresponsive to conventional therapies. Improved patient outcomes have resulted from advances in surgical techniques, organ preservation, and immunosuppression.

The global heart transplant market growth is attributed to the increasing burden of cardiovascular diseases such as ischemic heart disease and cardiomyopathies, increasing transplant infrastructure, and development of organ donation and allocation system. Increasing clinical awareness, increasing healthcare expenditure and technological advancements in preservation and monitoring technologies are further bolstering the adoption of heart transplantation in developed and emerging markets.

Market Dynamics

The global heart transplant market is driven by rising burden of end-stage heart failure associated with cardiovascular diseases, diabetes, obesity, and hypertension. The advent of mechanical circulatory support devices such as left ventricular assist devices (LVADs), normothermic organ perfusion and better preservation technologies are helping in the management of patients and increasing the availability of transplantable hearts. Growing investments in transplant infrastructure, organ donation, and transplant registries in developed as well as emerging markets are also driving market growth.

However, the growth of heart transplant market is limited by factors such as persistent shortage of donor hearts, high transplantation and lifelong post-operative care costs, and complications such as organ rejection and infections. Nevertheless, xenotransplantation, bioengineered heart technologies, and growing transplant capabilities in Asia Pacific, Latin America and the Middle East present significant opportunities to overcome organ shortages and expand access to sophisticated heart failure treatment.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global heart transplant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include TransMedics Group, Inc., XVIVO, Getinge AB, Terumo Corporation, Bridge to Life Ltd., Organ Recovery Systems, Inc., Paragonix Technologies, Inc., Preservation Solutions, Inc., Global Transplant Solutions, Inc., and LivaNova PLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global heart transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart transplant market

Market Segmentation

  • Transplant Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Orthotopic Heart Transplant
  • Heterotopic Heart Transplant
  • Donor Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Donation After Brain Death (DBD)
  • Donation After Circulatory Death (DCD)
  • Indication Insights (Revenue, USD Bn, 2021 - 2033)
  • End-Stage Heart Failure
  • Cardiomyopathy
  • Congenital Heart Disease
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialized Cardiac Transplant Centers
  • Academic and Research Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • TransMedics Group, Inc.
  • XVIVO
  • Getinge AB
  • Terumo Corporation
  • Bridge to Life Ltd.
  • Organ Recovery Systems, Inc.
  • Paragonix Technologies, Inc.
  • Preservation Solutions, Inc.
  • Global Transplant Solutions, Inc.
  • LivaNova PLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Heart Transplant Market, By Transplant Type
    • Global Heart Transplant Market, By Donor Type
    • Global Heart Transplant Market, By Indication
    • Global Heart Transplant Market, By End User
    • Global Heart Transplant Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Heart Transplant Market, By Transplant Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Orthotopic Heart Transplant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Heterotopic Heart Transplant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Heart Transplant Market, By Donor Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Donation After Brain Death (DBD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Donation After Circulatory Death (DCD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Heart Transplant Market, By Indication, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • End-Stage Heart Failure
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiomyopathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Congenital Heart Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Heart Transplant Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Specialized Cardiac Transplant Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Heart Transplant Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Transplant Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Donor Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Company Profile
    • TransMedics Group, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • XVIVO
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Getinge AB
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bridge to Life Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Organ Recovery Systems, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Paragonix Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Preservation Solutions, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Global Transplant Solutions, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • LivaNova PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us